JP2009535328A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535328A5
JP2009535328A5 JP2009507631A JP2009507631A JP2009535328A5 JP 2009535328 A5 JP2009535328 A5 JP 2009535328A5 JP 2009507631 A JP2009507631 A JP 2009507631A JP 2009507631 A JP2009507631 A JP 2009507631A JP 2009535328 A5 JP2009535328 A5 JP 2009535328A5
Authority
JP
Japan
Prior art keywords
use according
caused
seq
syndrome
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009507631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535328A (ja
JP5323682B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2007/000413 external-priority patent/WO2007126363A2/en
Publication of JP2009535328A publication Critical patent/JP2009535328A/ja
Publication of JP2009535328A5 publication Critical patent/JP2009535328A5/ja
Application granted granted Critical
Publication of JP5323682B2 publication Critical patent/JP5323682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009507631A 2006-04-27 2007-04-27 コンパートメント症候群の治療における使用のための抗分泌性タンパク質 Active JP5323682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600933-6 2006-04-27
SE0600933 2006-04-27
PCT/SE2007/000413 WO2007126363A2 (en) 2006-04-27 2007-04-27 Antisecretory protein for use in the treatment of compartment syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010245989A Division JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Publications (3)

Publication Number Publication Date
JP2009535328A JP2009535328A (ja) 2009-10-01
JP2009535328A5 true JP2009535328A5 (https=) 2010-06-17
JP5323682B2 JP5323682B2 (ja) 2013-10-23

Family

ID=38655929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009507631A Active JP5323682B2 (ja) 2006-04-27 2007-04-27 コンパートメント症候群の治療における使用のための抗分泌性タンパク質
JP2010245989A Active JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010245989A Active JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Country Status (19)

Country Link
US (2) US8309513B2 (https=)
EP (2) EP2363140B1 (https=)
JP (2) JP5323682B2 (https=)
KR (3) KR101757523B1 (https=)
CN (3) CN104689299B (https=)
AT (1) ATE526031T1 (https=)
AU (1) AU2007244003B2 (https=)
BR (2) BRPI0710794A2 (https=)
CA (1) CA2650589C (https=)
DK (3) DK2037950T3 (https=)
ES (3) ES2472737T3 (https=)
IL (1) IL194774A (https=)
MX (1) MX2008013774A (https=)
NZ (2) NZ572256A (https=)
PL (2) PL2040734T3 (https=)
RU (2) RU2457853C2 (https=)
SG (1) SG171601A1 (https=)
WO (1) WO2007126363A2 (https=)
ZA (2) ZA200809116B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008013769A (es) * 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Uso de factores antisecretores para el tratamiento de hipertension intraocular.
MX2008013777A (es) * 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Usos medicos adicionales de la proteina antisecretora.
KR101757523B1 (ko) 2006-04-27 2017-07-12 란트만넨 아스-팍토르 아베 구획 증후군의 치료에 사용하기 위한 항분비 단백질
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
WO2010093324A1 (en) * 2009-02-11 2010-08-19 Lantmännen As-Faktor Ab Use of antisecretory factors (af) for optimizing cellular uptake
WO2010065342A1 (en) 2008-11-25 2010-06-10 Temple University Angiocidin inhibition of tumor cell growth
US11253552B2 (en) 2015-07-10 2022-02-22 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of AF-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
JP7217760B2 (ja) * 2018-06-28 2023-02-03 ラントメネン・メディカル・アーベー 急性呼吸不全の治療および/または予防の使用のための抗分泌因子
CN112770643A (zh) 2018-09-28 2021-05-07 兰特门内保健食品公司 包含麦芽化脱壳燕麦的可消耗产品
EP3855935A1 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted wheat
AU2021243735A1 (en) 2020-03-26 2022-10-13 Lantmännen Functional Foods Ab A consumable product comprising malted cereals for promoting recovery at physical activity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) * 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
US7662169B2 (en) * 2000-09-05 2010-02-16 Wittmann Dietmar H Prosthesis and method for lowering abdominal pressure
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
MX2008013777A (es) 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Usos medicos adicionales de la proteina antisecretora.
KR101757523B1 (ko) 2006-04-27 2017-07-12 란트만넨 아스-팍토르 아베 구획 증후군의 치료에 사용하기 위한 항분비 단백질
US8329650B2 (en) * 2007-10-19 2012-12-11 Trustees Of Boston University Method of treating ischemic injury with follistatin-like 1 polypeptide

Similar Documents

Publication Publication Date Title
JP2009535328A5 (https=)
US7420033B2 (en) Composition of lactoferrin related peptides and uses thereof
JP5969457B2 (ja) 化合物およびそれらの使用
RU2008146734A (ru) Новый подход к лечению компартмент-синдрома
EP3305305B1 (en) Silicate containing compositions and methods of treatment
JPH11514990A (ja) 2−メルカプトエタノールアミン(2−mea)と類縁アミノチオール化合物および3,5−ジイソプロピルサリチル酸銅(▲ii▼)と類縁化合物の、各種疾患を予防および治療するための使用
US6486132B2 (en) Immunomodulator, immunomodulator food and immunomodulator feed
JPH07108857B2 (ja) 炎症過程及びアレルギー性疾患の予防及び治療のための細菌性製剤
US4384001A (en) Treatment of tumors with thiazolidine-4-carboxylic acid
JPS6320807B2 (https=)
MX2014003256A (es) Uso de hidroxamatos de indolilo e indolinilo para tratar insuficiencia cardiaca o lesion neuronal.
JP2009509532A (ja) コンドロイチナーゼabci変異体を用いた組成物およびその使用方法
CN115778936B (zh) 松萝酸协同增效多黏菌素在抗革兰氏阴性细菌感染中的应用
CN117205188A (zh) 维生素k4在制备治疗黑色素瘤的药物中的应用
CA1285226C (en) Compositions containing a 2,4-diamino-pyrimidine and sulphadimidine
CN116732006B (zh) 副溶血弧菌噬菌体解聚酶及其应用
KR102952115B1 (ko) 에드워드시엘라 피시사이다에 대해 특이적 용균 활성을 갖는 박테리오파지 및 이를 포함하는 항균 조성물
KR101971572B1 (ko) 신규한 살모넬라 엔테리티디스 특이 박테리오파지 및 이를 포함하는 항균 조성물
KR102608336B1 (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
RU2258501C2 (ru) Способ применения этидия бромистого для лечения пироплазмоза лошадей
JP2002265354A (ja) 抗ピロリ菌剤組成物
CN103285381B (zh) 核糖核酸酶和斑蝥素的联用
WO2012070967A1 (ru) Ранозаживляющая, противоожоговая, регенерирующая и противовирусная фармацевтическая композиция для местного применения
CN106798916A (zh) 一种治疗hpv感染的组合物及其应用